Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS vs CT for Kidney Stone Patients
NCT03058614Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jun 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sulfur hexafluoride in nephrolithiasis, sponsored by University of California, San Francisco. Planned start Jun 2017; status: withdrawn.
02
Drugs
sulfur hexafluoride
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT03058614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058614.